Procalcitonin as biomarker of antibiotic effectivity in communityacquired pneumonia

• المؤلفون الرئيسيون: Ana Khusnul Faizah, -, Winariani, -, Yulistiani, -, Samirah, -
• التنسيق: مقال PeerReviewed
• اللغة: English; English; English
• منشور في: Universitas Airlangga 2015
• الموضوعات: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• الوصول للمادة أونلاين: https://repository.unair.ac.id/124105/4/Bukti%20C-16%20Artikel.pdf; https://repository.unair.ac.id/124105/2/Bukti%20C-16%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/124105/3/Bukti%20C-16%20Turnitin.pdf; https://repository.unair.ac.id/124105/; https://journal.unair.ac.id/FMI@procalcitonin-as-biomarker-of-antibiotic-effectivity-in-communityacquired-pneumonia-article-9476-media-3-category-3.html

Major therapy for community-acquired pneumonia (CAP) is antibiotics. Procalcitonin used as the measure of antibioticseffectiveness. Procalcitonin is specific biomarker that elevates in acute bacterial infection. This study aimed to analyze procalcitoninas effective antibiotics biomarker in CAP patie...